B
BetterOmics
An AI cloud for omics data analysis, providing a centralized platform for reproducible validation, data traceability, and AI-powered insights, and featuring secure clinical-grade security and GxP…
About BetterOmics
Betteromics is a cutting-edge startup that specializes in managing and analyzing complex life science data. The company operates in the biotechnology and healthcare sectors, providing a comprehensive platform for handling multi-omics data. "Omics" refers to fields of study in biology ending in -omics, such as genomics, proteomics, and metabolomics, which involve large-scale data analysis.
Read full description
Betteromics serves a diverse range of clients, including pharmaceutical companies, research institutions, and healthcare providers. These clients require robust data management solutions to conduct high-throughput screening, multi-omic clinical studies, process monitoring, and manufacturing quality control. The platform helps these organizations break down data silos—isolated data storage systems that don't communicate with each other—allowing for integrated analysis and more informed decision-making.
The company operates as a Private SaaS (Software as a Service) deployed in the client's Virtual Private Cloud (VPC). This means that Betteromics provides a cloud-based software solution that is hosted on the client's private network, ensuring data security and compliance. The platform leverages Amazon Web Services (AWS) for its cloud infrastructure, ensuring scalability and reliability.
Betteromics makes money through a subscription-based business model. Clients pay for access to the platform, which includes features like data collection, processing, and analysis. The company also offers additional services such as custom integrations and premium support, providing multiple revenue streams.
In summary, Betteromics is revolutionizing the way life science data is managed and analyzed, offering a secure, scalable, and integrated solution for its clients.
At a glance
- Status
- Operational
- Founded
- 2020
- Headquarters
- Redwood City, United States
- Employees
- 11
- Open positions
- None listed
- Dealroom signal
- 60.7/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Cloud Data Services, Biotechnology, Core AI, Tech for Biotech and Pharma, Biotech and Pharma, Hard Tech, Woman Founder, AI Applications
- Technology
- Artificial Intelligence
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Oct 2023 | $20M | $80M | Sofinnova Partners · Triatomic Capital · SHAKTI | ↗ |
Growth signals
Latest recorded traffic for BetterOmics is 710 monthly website visits, down 49.3% over the last three months. BetterOmics's team declined 15.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Sofinnova Partners
Triatomic Capital
SHAKTI
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about BetterOmics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BetterOmics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.